HUMANA INC (HUM) Current Ratio
- Current ratio · latest quarter: Value 1.77×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.77× | Current assets / current liabilities. $38.08B ÷ $21.51B ≈ 1.77× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 38.08B USD | Assets, Current |
| Current obligations | 21.51B USD | Liabilities, Current |
| Cash and equivalents | 4.95B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $38.08B | $21.51B | $4.95B | (m) | (m) | (m) | (m) | (m) | 1.77× |
| 2025-12-31 | $32.73B | $16.35B | $4.20B | (m) | (m) | (m) | (m) | (m) | 2.00× |
| 2025-09-30 | $32.75B | $16.18B | $5.39B | (m) | (m) | (m) | (m) | (m) | 2.02× |
| 2025-06-30 | $33.62B | $17.22B | $4.04B | (m) | (m) | (m) | (m) | (m) | 1.95× |
| 2025-03-31 | $34.42B | $18.04B | $4.25B | (m) | (m) | (m) | (m) | (m) | 1.91× |
| 2024-12-31 | $29.82B | $16.94B | $2.22B | (m) | (m) | (m) | (m) | (m) | 1.76× |
| 2024-09-30 | $32.93B | $18.73B | $5.12B | (m) | (m) | (m) | (m) | (m) | 1.76× |
| 2024-06-30 | $32.86B | $19.79B | $5.50B | (m) | (m) | (m) | (m) | (m) | 1.66× |
| 2024-03-31 | $32.80B | $19.69B | $5.91B | (m) | (m) | (m) | (m) | (m) | 1.67× |
| 2023-12-31 | $29.99B | $18.87B | $4.69B | (m) | (m) | (m) | (m) | (m) | 1.59× |
| 2023-09-30 | $38.25B | $27.82B | $15.15B | (m) | (m) | (m) | (m) | (m) | 1.37× |
| 2023-06-30 | $38.76B | $28.28B | $16.21B | (m) | (m) | (m) | (m) | (m) | 1.37× |
| 2023-03-31 | $37.53B | $26.94B | $13.73B | (m) | (m) | (m) | (m) | (m) | 1.39× |
| 2022-12-31 | $26.18B | $17.18B | $5.06B | (m) | (m) | (m) | (m) | (m) | 1.52× |
| 2022-09-30 | $33.71B | $25.05B | $13.56B | (m) | (m) | (m) | (m) | (m) | 1.35× |
| 2022-06-30 | $27.22B | $17.84B | $5.15B | (m) | (m) | (m) | (m) | (m) | 1.53× |
| 2022-03-31 | $26.84B | $17.53B | $4.86B | (m) | (m) | (m) | (m) | (m) | 1.53× |
| 2021-12-31 | $24.89B | $15.33B | $3.39B | (m) | (m) | (m) | (m) | (m) | 1.62× |
| 2021-09-30 | $25.82B | $15.03B | $4.30B | (m) | (m) | (m) | (m) | (m) | 1.72× |
| 2021-06-30 | $25.79B | $15.05B | $3.38B | (m) | (m) | (m) | (m) | (m) | 1.71× |
| 2021-03-31 | $25.53B | $15.30B | $3.88B | (m) | (m) | (m) | (m) | (m) | 1.67× |
| 2020-12-31 | $23.64B | $13.39B | $4.67B | (m) | (m) | (m) | (m) | (m) | 1.77× |
| 2020-09-30 | $27.03B | $14.90B | $7.99B | (m) | (m) | (m) | (m) | (m) | 1.81× |
| 2020-06-30 | $27.87B | $16.45B | $7.16B | $12.84B | (m) | (m) | (m) | (m) | 1.69× |
| 2020-03-31 | $24.55B | $14.83B | $6.05B | $11.10B | (m) | (m) | (m) | (m) | 1.66× |
| 2019-12-31 | $19.89B | $10.93B | $4.05B | (m) | (m) | (m) | (m) | (m) | 1.82× |
| 2019-09-30 | $20.32B | $11.11B | $5.53B | $10.43B | (m) | (m) | (m) | (m) | 1.83× |
| 2019-06-30 | $20.16B | $11.54B | $4.78B | $9.99B | (m) | (m) | (m) | (m) | 1.75× |
| 2019-03-31 | $19.67B | $11.93B | $3.88B | $9.88B | (m) | (m) | (m) | (m) | 1.65× |
| 2018-12-31 | $16.95B | $10.08B | $2.34B | $10.03B | (m) | (m) | (m) | (m) | 1.68× |
| 2018-09-30 | $19.08B | $11.32B | $4.14B | $9.70B | (m) | (m) | (m) | (m) | 1.68× |
| 2018-06-30 | $26.86B | $18.77B | $8.05B | $9.46B | (m) | (m) | (m) | (m) | 1.43× |
| 2018-03-31 | $23.93B | $15.46B | $8.86B | $9.74B | (m) | (m) | (m) | (m) | 1.55× |
| 2017-12-31 | $17.40B | $9.41B | $4.04B | $9.56B | (m) | (m) | (m) | (m) | 1.85× |
| 2017-09-30 | $23.18B | $14.42B | $9.87B | $8.62B | (m) | (m) | (m) | (m) | 1.61× |
| 2017-06-30 | $22.57B | $13.71B | $8.14B | $8.12B | (m) | (m) | (m) | (m) | 1.65× |
| 2017-03-31 | $22.32B | $13.50B | $8.43B | $8.21B | (m) | (m) | (m) | (m) | 1.65× |
| 2016-12-31 | $16.19B | $7.82B | $3.88B | $7.59B | (m) | (m) | (m) | (m) | 2.07× |
| 2016-09-30 | $19.65B | $11.82B | $6.77B | $7.33B | (m) | (m) | (m) | (m) | 1.66× |
| 2016-06-30 | $17.74B | $9.93B | $2.43B | $7.42B | (m) | (m) | (m) | (m) | 1.79× |
| 2016-03-31 | $17.84B | $10.11B | $2.80B | $7.74B | (m) | (m) | (m) | (m) | 1.77× |
| 2015-12-31 | $15.71B | $8.15B | $2.57B | $7.27B | (m) | (m) | (m) | (m) | 1.93× |
| 2015-09-30 | $15.77B | $7.74B | $1.60B | $7.42B | (m) | (m) | (m) | (m) | 2.04× |
| 2015-06-30 | $16.98B | $8.97B | $2.25B | $7.04B | (m) | (m) | (m) | (m) | 1.89× |
| 2015-03-31 | $17.40B | $9.18B | $1.95B | $7.60B | (m) | (m) | (m) | (m) | 1.90× |
| 2014-12-31 | $15.54B | $7.47B | $1.94B | $7.60B | (m) | (m) | (m) | (m) | 2.08× |
| 2014-09-30 | $15.64B | $7.77B | $2.71B | $8.09B | (m) | (m) | (m) | (m) | 2.01× |
| 2014-06-30 | $14.09B | $7.88B | $1.59B | $7.57B | (m) | (m) | (m) | (m) | 1.79× |
| 2014-03-31 | $13.97B | $7.71B | $1.66B | $8.25B | (m) | (m) | (m) | (m) | 1.81× |
| 2013-12-31 | $12.30B | $6.32B | $1.14B | $8.09B | (m) | (m) | (m) | (m) | 1.95× |
| 2013-09-30 | $12.57B | $6.55B | $1.25B | $8.26B | (m) | (m) | (m) | (m) | 1.92× |
| 2013-06-30 | $12.63B | $6.77B | $1.52B | $7.56B | (m) | (m) | (m) | (m) | 1.87× |
| 2013-03-31 | $12.68B | $6.94B | $1.40B | $8.14B | (m) | (m) | (m) | (m) | 1.83× |
| 2012-12-31 | $11.71B | $6.38B | $1.31B | $8.00B | (m) | (m) | (m) | (m) | 1.84× |
| 2012-09-30 | $11.68B | $6.37B | $1.36B | $8.06B | (m) | (m) | (m) | (m) | 1.83× |
| 2012-06-30 | $14.07B | $8.68B | $3.87B | $7.88B | (m) | (m) | (m) | (m) | 1.62× |
| 2012-03-31 | $14.06B | $8.82B | $3.66B | $7.89B | (m) | (m) | (m) | (m) | 1.59× |
| 2011-12-31 | $11.18B | $6.06B | $1.38B | $7.74B | (m) | (m) | (m) | (m) | 1.85× |
| 2011-09-30 | $13.63B | $8.52B | $4.02B | $7.86B | (m) | (m) | (m) | (m) | 1.60× |
| 2011-06-30 | $11.48B | $6.36B | $1.57B | $7.61B | (m) | (m) | (m) | (m) | 1.81× |
| 2011-03-31 | $11.10B | $6.36B | $1.76B | $7.42B | (m) | (m) | (m) | (m) | 1.74× |
| 2010-12-31 | $10.14B | $5.74B | $1.67B | $6.87B | (m) | (m) | (m) | (m) | 1.76× |
| 2010-09-30 | $11.38B | $6.26B | $2.92B | $7.14B | (m) | (m) | (m) | (m) | 1.82× |
| 2010-06-30 | $10.79B | $6.00B | $2.00B | $6.88B | (m) | (m) | (m) | (m) | 1.80× |
| 2010-03-31 | $10.26B | $5.91B | $1.81B | $6.76B | (m) | (m) | (m) | (m) | 1.74× |
| 2009-12-31 | $9.25B | $5.26B | $1.61B | $6.19B | (m) | (m) | (m) | (m) | 1.76× |
| 2009-09-30 | $9.24B | $5.51B | $1.45B | $5.90B | (m) | (m) | (m) | (m) | 1.68× |
| 2009-06-30 | $8.77B | $5.47B | $1.59B | $4.58B | (m) | (m) | (m) | (m) | 1.60× |
| 2008-12-31 | $8.40B | $5.18B | $1.97B | $4.20B | (m) | (m) | (m) | (m) | 1.62× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |